SCHEMBL9871799

SCHEMBL9871799

CCc1c(Br)ccc(C(=O)O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
RXFP1 Q9HBX9 2/20 0.43
PRNP P04156 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PPARG P37231 1/20 0.43
HIF1A Q16665 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NR2E3 Q9Y5X4 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
TSHR P16473 2/20 0.39
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4817993 0.85 GABRP (0.39) CYP1A2RXFP1PRNPCYP2C9CYP2C19
SCHEMBL10901788 0.84 GABRP (0.43) CYP1A2RXFP1PRNPCYP2C9CYP2C19
SCHEMBL28733526 0.81 GABRP (0.41) CYP1A2RXFP1PRNPCYP2C9CYP2C19
SCHEMBL7409160 0.81 GABRP (0.41) CYP1A2TSHRGABRPGABRDGABRA1
SCHEMBL31535191 0.80 TSHR (0.38) CYP1A2RXFP1PRNPCYP2C9CYP2C19
SCHEMBL28670020 0.79 CSNK2A1 (0.46) CYP1A2TSHRGABRPGABRDGABRA1
SCHEMBL7410303 0.79 GABRP (0.37) CYP1A2RXFP1PRNPCYP2C9CYP2C19
SCHEMBL1251359 0.78 CYP1A2 (0.44) CYP1A2RXFP1TSHRGABRPGABRD
SCHEMBL21723600 0.78 GABRP (0.39) CYP1A2TSHRGABRPGABRDGABRA1
SCHEMBL598480 0.78 PTGS2 (0.42) CYP1A2CYP2C9CYP2C19HIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5008285-A Antiarthritic agent with low gastric irritability side effect HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-16 US disclosed
EP-0160258-B1 (6,11-DIHYDRO-11-OXODIBENZ(BM,E)OXEPINYL)PENTANOLS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-09-27 EP disclosed
EP-0159684-B1 (6,11-DIHYDRO-11-OXODIBENZ(B,E)OXEPINYL)PENTANOIC ACIDS AND DERIVATIVES, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-09-27 EP disclosed
EP-0160258-A2 (6,11-Dihydro-11-oxodibenz(bm,e)oxepinyl)pentanols, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-11-06 EP disclosed
EP-0159684-A2 (6,11-Dihydro-11-oxodibenz(b,e)oxepinyl)pentanoic acids and derivatives, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-10-30 EP disclosed